Management team

The management team assists the CEO in matters such as strategy, operating principles and other business undertakings, as well as matters concerning the entire company. The chairman of the management team is the CEO of FIT Biotech.

Management team members are:

Chairman
Erkki Pekkarinen

Chief Executive Officer

  • MBA
  • Currently CEO and Board member in a biopharmaceutical company
  • A variety of managerial positions in investment activities and financial administration, incl. Director of Finance at the Local Government Pensions Institution. He has also worked in municipal finances and funding. In addition, he has worked extensively consulting, for example as a restructuring consultant
  • Has served as member and as Chairman in several Boards

Santeri Kiviluoto

Vice President, Chief Scientific Officer

  • PhD in Biomedical Sciences from KU Leuven, Belgium, MSc in Biochemistry, and BSc in Economics and Business Administration from Åbo Akademi University, Finland
  • Over ten years of experience in biomedical research at leading institutions (Yale University, KU Leuven, Karolinska Institutet, VTT Medical Biotechnology)
  • Active in new business development in Europe and the US

Kalevi Reijonen

Senior Vice President, Chief Medical Officer

  • Licentiate of Medicine
  • CEO and President of FIT Biotech in 2003-2015
  • 40 years of international experience in the pharmaceutical and biotech industry (e.g. Spectrum Medical Sciences, Orion Corporation and Farmos Inc., USA
  • Has negotiated several global licenses with Big Pharma
  • Currently serves as the Chairman of the Supervisory Board of Icosagen A/S Estonia

Tommi Holopainen

Chief Financial Officer

  • Joined FIT Biotech in 2018
  • Born 1964, citizen of Finland
  • Has experience from various leadership positions in Telia starting from 1995. Tommi has served as the Chief Financial Officer of both Telia’s Swedish and Nepalese units and as a business development director for Telia in Sweden and Russia. In addition, he has been in charge of Telia’s acquisition activities in Eurasia area, as well as product management and strategy process in Finland
  • Holds a Master of Science in economics and eMBA

Liisa Laitinen (on sick leave)

Senior Vice President, Country Manager and Chief Financial Officer

  • Responsible for finance and administration as well as managing FIT’s operations in Tampere, Finland, including the GMP-manufacturing facility
  • Associate in Business Administraton
  • Over 30 years of experience in international business in Finland and abroad (e.g. Paloheimo Group, Dresdner Bank, Bank of America)
  • Currently serves on the Supervisory Board of Icosagen A/S Estonia and the Supervisory Board of Bank and Insurance Company LähiTapiola Pirkanmaa, Finland

Matti Lähde

Vice President, Production and Tampere Operations

  • M.Sc. (Biochemistry and Molecular Biology)
  • Joined FIT Biotech in 2015
  • Long experience in the research, process development and biological production
  • Prior to joining FIT Biotech Oy he was employed by Ark Therapeutics Oy, responsible for the manufacturing of Gene Therapy Products in cGMP environment, and employed by Biofile Ltd
  • Also experience from cancer research with Orion and virology research at Turku University

Jussi Seitsonen

Vice President, Quality Assurance and Quality Control

  • M.Sc.
  • Quality Responsible Director (QP=Qualified Person)
  • Quality Assurance and Quality Control Manager of FIT Biotech since 2000
  • Experienced in EU Pharmaceutical legislation and Finnish Medicines Act
  • Prior joining FIT Biotech, worked at Leiras Turku as Microbiologist in Quality Control